Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration date novartis gsk composition matter?When will a generic version of xiaflex be available?Zemdri nce gain exclusivity 2028 patent 2031?When will tenofovir alafenide come off patent in canada?Testosterone enanthate expiration?
See the DrugPatentWatch profile for nivolumab
Nivolumab is made by Bristol Myers Squibb (BMS). Nivolumab is the active ingredient in the immunotherapy brand Opdivo (nivolumab).
In practice, many countries and markets can involve local manufacturers for supply and packaging, but the drug’s developer/primary company associated with nivolumab is Bristol Myers Squibb.
If you’re looking for patent/exclusivity and manufacturer details tied to nivolumab in specific regions, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/
Other Questions About Nivolumab :